Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years

Regeneron Pharmaceuticals REGN has outperformed the market over the past 20 years by 15.96% on an annualized basis producing an average annual return of 23.84%. Currently, Regeneron Pharmaceuticals has a market capitalization of $100.69 billion.

Buying $100 In REGN: If an investor had bought $100 of REGN stock 20 years ago, it would be worth $7,527.35 today based on a price of $913.82 for REGN at the time of writing.

Regeneron Pharmaceuticals's Performance Over Last 20 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.